Medical Innovation Acceleration Act of 2020
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 19, 2020)
Medical Innovation Acceleration Act of 2020
This bill exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
What just happenedMay 19, 2020
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseMay 19, 2020
- May 19, 2020IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 19, 2020IntroReferralIntro-H
Introduced in House
- May 19, 2020IntroReferral1000
Introduced in House